How well does Astrazeneca’s corona vaccine actually protect? According to the British-Swedish pharmaceutical company, the vaccine is 76 percent effective. For over 65-year-olds, this value is 85 percent, as the data from the third phase of the clinical study show.
This means that among the older subjects in the vaccinated group, 85 percent fewer diseases occurred than among those in a control group. 32,599 subjects took part in the study. The protection against a severe course of the disease is 100 percent.
Old data published
On Monday, however, the company announced that the vaccine was 79 percent effective against corona. On Tuesday, the US health authority questioned the validity of the data. Astrazeneca fell back and had to admit that the data of an interim analysis have been published. And promised to deliver the correct data within 48 hours.
The published data are now the most recent results. The vaccine was well tolerated and no safety concerns were identified. “We look forward to submitting the application for emergency approval in the USA in the coming weeks,” says Astrazeneca research director, Mene Pangalos.
In the meantime stopped
The British-Swedish company developed the vaccine called AZD1222 together with Oxford University. It has been used on a large scale in the UK since January. Switzerland has ordered 5.3 million doses of the vaccine if the therapeutic products authority Swissmedic also allows the vaccine.
Germany and several other countries had suspended the vaccination with the Astrazeneca substance for the time being because several cases of thrombosis (blood clots) in the cerebral veins were reported in relation to the vaccination. The vaccine is now being used again. (lui / SDA)
Published: 03/25/2021, 51 minutes ago